An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A

Journal of Virology

Volumn 75, Issue 18, 2001, Pages 8556-8568

  Lee, W ^a   Hwang, Y H ^a   Lee, S K ^a   Subramanian, C ^a   Robertson, E S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EARLY ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 3A; GLYCOPROTEIN GP 350; HYBRID PROTEIN; LATENT MEMBRANE PROTEIN 1; PHORBOL ESTER; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE DELETION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOCYTE TRANSFORMATION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS REPLICATION;

ANIMALS; B-LYMPHOCYTES; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CALLITHRIX; CELL LINE; DEOXYRIBONUCLEASE BAMHI; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE GLYCOPROTEINS; OPEN READING FRAMES; PHORBOL ESTERS; POLYMERASE CHAIN REACTION; SEQUENCE DELETION; VIRAL MATRIX PROTEINS;

EID: 0034886202     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.18.8556-8568.2001     Document Type: Article

References (73)

1. EBV-activation of human B-lymphocytes
2. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
3. Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells
4. NF-κB inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells
5. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells
6. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: Potential switches in latent gene expression due to coinfection
7. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes
8. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation
9. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
10. Modulation of histone acetyl-transferase activity through interaction of Epstein-Barr nuclear antigen 3C with prothymosin alpha
11. Epstein-Barr virus (B95-8) DNA VII: Molecular cloning and detailed mapping
12. The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame
13. Epstein-Barr virus genes and cancer cells
14. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes
15. Sequence analysis of Raji Epstein-Barr virus DNA
16. Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells
17. + T lymphocytes
18. Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation
19. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation
20. Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands
21. Organization of the Epstein-Barr virus DNA molecule. II. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript
22. Sequences of the Epstein-Barr virus (EBV) large internal repeat form the center of a 16-kilobase-pair palindrome of EBV (P3HR-1) heterogeneous DNA
23. Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency
24. The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus
25. Epstein-Barr virus carried by Raji cells: A mutant in early functions?
26. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation
27. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues
28. Immortalization of human primary B lymphocytes in vitro with DNA
29. Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA
30. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2
31. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines
32. Specifically mutated Epstein-Barr virus recombinants: Defining the minimal transforming genome for primary B cell transformation
33. Biochemistry of latent Epstein-Barr virus infection and associated cell growth transformation
34. EpsteinBarr virus DNA. XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion
35. The complexity of the Epstein-Barr virus infection in humans
36. B-lymphoblastoid cell lines from cancer patients
37. Regulation of Epstein-Barr virus latency by latent membrane protein 2
38. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential
39. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B
40. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation
41. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody
42. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
43. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: Sequence homology of gp350 and C3 complement fragment C3d
44. Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells
45. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region
46. DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus
47. Non-immortalizing P3J-HR-1 Epstein-Barr virus: A deletion mutant of its transforming parent, Jijoye
48. Introduction: Viruses and human cancer
49. Burkitt's lymphoma
50. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs
51. Epstein-Barr virus vectors for gene delivery to B lymphocytes
52. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro
53. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro
54. Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1
55. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes
56. A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection
57. Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H
58. Interaction of the B95-8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes
59. Recombinant EpsteinBarr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro
60. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro
61. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation
62. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element
63. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1
64. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
65. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
66. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas
67. A major DNA binding protein encoded by BALF2 open reading frame of Epstein-Barr virus (EBV) forms a complex with other EBV DNA-binding proteins: DNase, EA-D, and DNA polymerase
68. Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells
69. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells